Inhibition of TER94 in the motor neurons influences longevity and reduces locomotor ability
The inhibition of TER94 via the UAS-TER94-RNAiGL00448 transgene through D42-Gal4 resulted in a slight reduction in median lifespan compared to the control UAS-lacZ median lifespan of 70 days, inhibition of TER94 via TER94-RNAiGL00448 lead to a median lifespan of 68 days (Fig. 1a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 8 weeks the TER94-RNAiGL00448 flies lost their ability to climb at week 4 (Fig. 1b). The inhibition of TER94 via the UAS-TER94-RNAiHMS00656 transgene through D42-Gal4 resulted in a significant increase in median lifespan, compared to the control UAS-lacZ median lifespan of 70 days, inhibition of TER94 via TER94-RNAiHMS00656 lead to a median lifespan of 80 days (Fig. 1a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 8 weeks the TER94-RNAiHMS00656 flies lost their ability to climb at week 3 (Fig. 1b). The inhibition of TER94 via UAS-TER94-RNAiJF03402 transgene through D42-Gal4 resulted in a significant increase in median lifespan compared to the control UAS-lacZ median lifespan of 70 days, inhibition of TER94 via TER94-RNAiJF03402 lead to a median lifespan of 78 days (Fig. 1a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 8 weeks the TER94-RNAiJF03402 flies lost their ability to climb at week 3 (Fig. 1b).
Inhibition of TER94 in the dopaminergic neurons reduces both longevity and locomotor ability
The inhibition of TER94 via UAS-TER94-RNAiGL00448 through TH-Gal4 resulted in a significant reduction in median lifespan compared to the control UAS-lacZ median lifespan of 82 days, inhibition of TER94 via TER94-RNAiGL00448 lead to a median lifespan of 54 days (Fig. 2a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 8 weeks the TER94-RNAiGL00448 flies lost their ability to climb at week 4 (Fig. 2b). The inhibition of TER94 via UAS-TER94-RNAiHMS00656 through TH-Gal4 resulted in a significant reduction in median lifespan compared to the control UAS-lacZ median lifespan of 82 days, inhibition of TER94 via TER94-RNAiHMS00656 lead to a median lifespan of 46 days (Fig. 2a) (Fig. 2a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 8 weeks the TER94-RNAiHMS00656 flies lost their ability to climb at week 4 (Fig. 2b).
Inhibition of TER94 in the ddc-Gal4HL4.3D-expressing neurons has a minimal impact longevity, and reduces locomotor ability
The inhibition of TER94 via the UAS-TER94-RNAiGL00448 transgene though ddc-Gal4HL4.3D resulted in a slight change in median lifespan compared to the control UAS-lacZ median lifespan of 70 days, inhibition of TER94 via TER94-RNAiGL00448 lead to a median lifespan of 68 days (Fig. 3a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 8 weeks the TER94-RNAiGL00448 flies lost their ability to climb at week 3 (Fig. 3b). The inhibition of TER94 via the UAS-TER94-RNAiHMS00656 transgene though ddc-Gal4HL4.3D resulted in a slight increase in median lifespan compared to the control UAS-lacZ median lifespan of 70 days, inhibition of TER94 via TER94-RNAiHMS00656 lead to a median lifespan of 74 days (Fig. 3a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 8 weeks the TER94-RNAiHMS00656 flies lost their ability to climb at week 4 (Fig. 3b).
Inhibition of TER94 and parkin in the ddc-Gal4HL4.3D-expressing neurons reduces longevity and locomotor ability
The co-inhibition of TER94 via UAS-TER94-RNAiGL00448 transgene and parkin through ddc-Gal4HL4.3D-expressing neurons resulted in a large reduction in median lifespan (by ~ 30%). Compared to the control UAS-lacZ median lifespan of 84 days, inhibition of TER94 via TER94-RNAiGL00448 lead to a median lifespan of 58 days (Fig. 4a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 5 weeks the TER94-RNAiGL00448 flies lost their ability to climb at week 3 (Fig. 4b).
Inhibition of TER94 in the ddc-Gal4HL4.36-expressing neurons increases longevity, and reduces locomotor ability
The inhibition of TER94 via the UAS-TER94-RNAiGL00448 though ddc-Gal4HL4.36 resulted in a significant increase in median lifespan compared to the control UAS-lacZ median lifespan of 79 days, inhibition of TER94 via TER94-RNAiGL00448 lead to a median lifespan of 88 days (Fig. 5a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 5 weeks the TER94-RNAiGL00448 flies lost their ability to climb also at week 4, however their climbing ability was drastically poorer (Fig. 5b). The inhibition of TER94 via UAS-TER94-RNAiHMS00656 though ddc-Gal4HL4.36 resulted in a significant increase in median lifespan compared to the control UAS-lacZ median lifespan of 79 days, inhibition of TER94 via TER94-RNAiHMS00656 lead to a median lifespan of 90 days (Fig. 5a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 5 weeks the TER94-RNAiHMS00656 flies lost their ability to climb also at week 4, however their climbing ability was drastically poorer (Fig. 5b). The inhibition of TER94 via the UAS-TER94-RNAiJF03402 transgene though ddc-Gal4HL4.36 resulted in a significant reduction in median lifespan compared to the control UAS-lacZ median lifespan of 79 days, inhibition of TER94 via TER94-RNAiJF03402 lead to a median lifespan of 44 days (Fig. 5a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 5 weeks the TER94-RNAiJF03402 flies lost their ability to climb also at week 4, however their climbing ability was drastically poorer (Fig. 5b).
Inhibition of TER94 and the co-expression of alpha-synuclein in the ddc-Gal4HL4.36-expressing neurons increases longevity, and reduces locomotor ability
The inhibition of TER94 via the UAS-TER94-RNAiGL00448 transgene and the co-expression of alpha-synuclein through ddc-Gal4HL4.36-expressing neurons resulted in a significant reduction in median lifespan compared to the control UAS-lacZ median lifespan of 86 days, inhibition of TER94 via TER94-RNAiGL00448 lead to a median lifespan of 80 days (Fig. 6a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 4 weeks the TER94-RNAiGL00448 flies lost their ability to climb at week 3 (Fig. 6b).The inhibition of TER94 via the UAS-TER94-RNAiJF03402 transgene and the co-expression of alpha-synuclein through ddc-Gal4HL4.36-expressing neurons resulted in a significant reduction in median lifespan compared to the control UAS-lacZ median lifespan of 86 days, inhibition of TER94 via TER94-RNAiJF03402 lead to a median lifespan of 48 days (Fig. 6a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 4 weeks the TER94-RNAiJF03402 flies lost their ability to climb at week 2 (Fig. 6b).The inhibition of TER94 via the UAS-TER94-RNAiHMS00656 transgene and the co-expression of alpha-synuclein through ddc-Gal4HL4.36-expressing neurons resulted in a large increase in median lifespan (by ~ 28%). Compared to the control UAS-lacZ median lifespan of 86 days, inhibition of TER94 via TER94-RNAiHMS00656 lead to a median lifespan of 110 days (Fig. 6a). Locomotor ability was reduced over time compared to the control UAS-lacZ which maintained strong climbing ability well into the 4 weeks the TER94-RNAiHMS00656 flies lost their ability to climb at week 3 (Fig. 4b).